Hydroxamic acid esters and pharmaceutical use thereof

Details Hydroxamic acid esters and pharmaceutical use thereof Hydroxamic acid esters and pharmaceutical use thereof

2004-12-02

2011-10-11

Solola, Taofiq A (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S109000

Reexamination Certificate

active

08034811

ABSTRACT:
The invention relates to compounds of general formula Iwherein D, E, F, G, W, Y, R1, A, R9, X, B, R8are as defined herein, and pharmaceutically acceptable salts, hydrates, or solvates thereof, for use—alone or in combination with one or more other pharmaceutically active compounds—in therapy, for treating diseases associated with deregulated angiogenesis, such as cancer.

REFERENCES:
patent: 5155110 (1992-10-01), Connor et al.
patent: 6147107 (2000-11-01), Dent et al.
patent: 2092852 (1993-10-01), None
patent: 0 475 206 (1992-03-01), None
patent: 0 711 757 (1996-05-01), None
patent: 1 321 518 (2003-06-01), None
patent: 1126672 (1965-12-01), None
patent: 1 126 672 (1968-09-01), None
patent: 1 126 672 (1968-09-01), None
patent: 2000-281659 (2000-10-01), None
patent: 2002-6453 (2002-01-01), None
patent: 2004-075614 (2004-03-01), None
patent: 6515475 (1965-11-01), None
patent: WO-95/25723 (1995-09-01), None
patent: WO 97/10228 (1997-03-01), None
patent: WO 97/30047 (1997-08-01), None
patent: WO 98/14438 (1998-04-01), None
patent: WO-99/01426 (1999-01-01), None
patent: WO-99/01428 (1999-01-01), None
patent: WO 00/15222 (2000-03-01), None
patent: WO-00/35436 (2000-06-01), None
patent: WO-00/40235 (2000-07-01), None
patent: WO-00/41505 (2000-07-01), None
patent: WO-01/68619 (2001-09-01), None
patent: WO 01/70671 (2001-09-01), None
patent: WO-02/06213 (2002-01-01), None
patent: WO-02/18319 (2002-03-01), None
patent: WO-02/055501 (2002-07-01), None
patent: 02/066470 (2002-08-01), None
patent: WO 02/066454 (2002-08-01), None
patent: WO-02/068406 (2002-09-01), None
patent: WO-02/076496 (2002-10-01), None
patent: WO-03/024222 (2003-03-01), None
patent: WO-03/062189 (2003-07-01), None
patent: WO-03/062191 (2003-07-01), None
patent: WO-2004/037853 (2004-05-01), None
King, Med Chem: Principle and Practice (1994), p. 206-208.
Kalgutkar A S et al., Bioorganic & Medicinal Chemistry Letters, Oxford, GB, vol. 12, 2002, pp. 521-524.
Mamalis et al., Journal of the Chemical Society, Chemical Society, Letchworth, GB, 1965, pp. 6278-6287.
Wolf et al., Justus Liebigs Annalen Der Chemie, Verlag Chemie GMBH, Weinheim, DE, 1975, pp. 1245-1250.
Allais A et al., Chimie Therapeutique, Editions Dimeo, Arcueil, FR, vol. 8, 1973, pp. 154-168.
Scott A W et al., Journal of Organic Chemistry, American Chemical Society, Easton, US vol. 7, No. 6, 1942, pp. 508-516.
El-Khamry A M et al., Die Pharmazie, May 1989, vol. 44, No. 5, pp. 312-315.
Kohl H et al., Justus Liebigs Annalen Der Chemie, Verlag Chemie GMBH, Weinheim, DE, vol. 766, 1972, pp. 106-115.
Concalves et al, “Acetylation of o-Aminobenzamidoxime”, Bulletin de la SocieteChimique de France 1970, 7, 2599-614.
Korbinits et al. “Ring Transformation of 1,2-Disubstituted 4(1H)-Quinazolone Oximes to 3,5-Disubstituted 1,2,4-Oxadiazoles”, Chemische Berichte, 1989, 122(6), 1107-12.
Korbonits et al, “Recent Results on the Cyclization Tendency of Diacyl 2-aminobenzaidoximes”, Acta Chimica Hungarica, 1990, 127(6), 795-802.
CA Accession No. 1991:6034 & CAS RN 129858-49-0. (1991).
CA Accession No. 2000:715593. (2000).
CA Accession No. 2002:658103. (2002).
Napoleone Ferrara et al., “The Biology of VEGF and its Receptors”, Nature Medicine, vol. 9, No. 6, Jun. 2003 pp. 669-676.
Peter Carmeliet, “Angiogenesis in Health and Disease”, Nature Medicine, vol. 9, No. 6, Jun. 2003, pp. 653-660.
Carmeliet et al., “Angiogenesis in cancer and other diseases”, Nature, vol. 407, Sep. 14, 2000, pp. 249-257.
Wolf et al., Cyclization Reactions of at the Amino Nitrogen Substituted O-Methyl o-Aminobenzohydroxamates, Liebigs Ann. Chem., 1975, pp. 1245-1251 w/translation.
Xuan et al,, “Effects of Crocin Analogs on Ocular Blood Flow and Retinal Function”, Journal of Ocular Pharmacology and Therapeutics, vol. 15, No. 2, 1999, pp. 143-152.
Yancopoulous et al., Vascular-specific growth factors and blood vessel formation, Nature, vol. 407, Sep. 2000, pp. 242-248.

Affiliated with

Also associated with

Rating

Hydroxamic acid esters and pharmaceutical use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hydroxamic acid esters and pharmaceutical use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxamic acid esters and pharmaceutical use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4287044